David P. Blakeman

Omeprazole, a specific inhibitor of gastric (H+-K+)-ATPase, is a H+-activated oxidizing agent of sulfhydryl groups.

Wha Bin Im, John C. Sih, David P. Blakeman et al. · Journal of Biological Chemistry · 1985 · 105 citations · Full text

Irreversible inactivation of rat gastric (H+-K+)-ATPase invivo by omeprazole

Wha Bin Im, David P. Blakeman, John P. Davis · Biochemical and Biophysical Research Communications · 1985 · 83 citations

Medicine, Physiology, Gastroenterology +5

Inhibition of (H+ + K+)-ATPase and H+ accumulation in hog gastric membranes by trifluoperazine, verapamil and 8-(N,N-diethylamino)octyl-3,4,5-trimethoxybenzoate

Wha Bin Im, David P. Blakeman, John Mendlein et al. · Biochimica et Biophysica Acta (BBA) - Biomembranes · 1984 · 58 citations

Chemical Biology, Medicinal Chemistry, Hog Gastric Membranes +7

Correlation between gamma-aminobutyric acidA receptor ligand-induced changes in t-butylbicyclophosphoro[35S]thionate binding and 36Cl- uptake in rat cerebrocortical membranes.

W B Im, David P. Blakeman · Molecular Pharmacology · 1991 · 50 citations

Studies on the mechanism of interactions between anesthetic steroids and gamma-aminobutyric acidA receptors.

Wha Bin Im, David P. Blakeman, John P. Davis et al. · Molecular Pharmacology · 1990 · 44 citations